Our experienced professionals have extensive expertise in immuno-oncology patents and provide strategic guidance and advice throughout the process.

How We Stand Out

• We give diligence its due. We apply rigorous quality control standards to ensure collected samples can be used immediately, not years later.
• Data drives our decision making. Our deep sample analyses provide a more holistic view of a patient’s cancer and their immune system’s defensive response, enabling science that will help treat more patients and cancers.
• Synergy is in our core. Our clinical trials and research studies are fully integrated within the BioTrust, which banks samples and reports testing results in a standardized way so comparisons across studies can further our understanding of immunotherapy’s promise and potential.
• We power the research engine. Researchers can access our growing collection of 30,000+ tissue and blood samples to inform their research. In turn, they contribute data to our knowledge engine for others to access and build upon.